We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice to the Prime Minister on how government can increase the contribution of science and technology for the sustainability of the UK’s health and care system
The Medicines and Healthcare products Regulatory Agency (MHRA) has today given approval for the first monoclonal antibody treatment for the prevention and treatment of COVID-19 in the UK.
First published during the 2019 to 2022 Johnson Conservative government
Thousands of patients in Cumbria will benefit from state-of-the-art cancer diagnosis and treatment at the Northern Centre for Cancer Care in Carlisle.
More than £6.9 billion has been committed to continue driving integration between health and social care and support local recovery from the pandemic.
Complete a short survey to help us set future criteria for accredited national nominating bodies and specialist societies. The survey closes on 27 September 2021.
This letter provides information on the introduction of the Shingrix® vaccine for immunocompromised individuals from 1 September 2021.
Public Health England (PHE) has issued a warning of a sharp rise in the number of overdoses linked to people using drugs in several areas across England.
The UK regulator has confirmed the vaccine is safe and effective in this age group.
The UK has delivered 299,700 doses of Oxford-AstraZeneca vaccine to Egypt as part of its efforts to ensure the most vulnerable are vaccinated.
Nuromol, a medicine that contains 200mg of ibuprofen and 500mg of paracetamol per tablet will become available without the need to visit a pharmacy
Correspondence between Imperial Tobacco UK and the Department of Health and Social Care, published under Article 5.3 of the WHO Framework Convention on Tobacco Control.
Young people urged to come forward for both doses to support cautious return to normal life.
Health and Social Care Secretary Sajid Javid officially opens the new centrepiece of the UK’s testing infrastructure, the Rosalind Franklin Laboratory.
We are seeking the views of industry, the medical community, patients and the public. The consultation will run for six weeks.
Correspondence between the UK Vaping Industry Association and the Department of Health and Social Care, published under Article 5.3 of the WHO Framework Convention on Tobacco Control.
Latest data shows 60,000 deaths and 66,900 hospitalisations have been prevented by the vaccines.
Patients should not stop any treatments without consulting their doctor or pharmacist
The Access Consortium has published a three-year strategy which aims to align regulatory approaches and policies to facilitate work-sharing on medicines
The latest REACT-1 study findings from Imperial College London and Ipsos MORI show COVID-19 infection rates are three times lower for double vaccinated people.
Consultation launched to make lifesaving medicine which can reverse the effects of an opioid overdose available to more frontline workers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).